Karen Maschke – Nonhuman Animals Containing Human Cells: Ethics and Oversight | GES Colloquium, Spring 2023

This presentation focuses on ethical and oversight issues as they relate to the insertion of human cells into nonhuman animals, e.g., “chimeric research.” ...

Continue reading "Karen Maschke – Nonhuman Animals Containing Human Cells: Ethics and Oversight | GES Colloquium, Spring 2023"

Fernanda Santos – GE Foods Regulation – The U.S. Way | GES Colloquium

This discussion aims to give participants some thought-provoking information on how food is generally regulated in the U.S., in addition to a general overview of the process utilized by the regulatory bodies to approve genetically engineered foods for human consumption. ...

Continue reading "Fernanda Santos – GE Foods Regulation – The U.S. Way | GES Colloquium"

Entomology Seminar: Zack Brown on Public Perceptions and Ex Ante Consumer Impacts of Gene Drives for Agricultural Insect Pests

Entomology Seminar, 11:15am - 12:15pm, Oct. 14. Thomas Hall, Room 3503 (Stephens Room). To watch the ENT seminar remotely via Zoom: https://ncsu.zoom.us/j/927923475...

Continue reading "Entomology Seminar: Zack Brown on Public Perceptions and Ex Ante Consumer Impacts of Gene Drives for Agricultural Insect Pests"

Todd Kuiken Seminar: CRISPR and Risk (RIT)

CRISPR and RISK - A Critical Discussion of Gene Editing; Rochester Institute of Technology, Feb 26, 2019. Speakers: Stephen Hilgartner, Cornell University, Department of Science and Technology Studies; Todd Kuiken,  Senior Research Scholar, Genetic Engineering and Society Center North Carolina State University; Patti Durr, RIT/NTID, Department of Cultural and Creative Studies...

Continue reading "Todd Kuiken Seminar: CRISPR and Risk (RIT)"

Todd Kuiken Seminar: Governance of Emerging Biotechnologies in a World Without Borders

Innovative Genomics Institute, UC Berkeley, Jan 22, 2019 | Todd Kuiken Seminar: Governance of Emerging Biotechnologies in a World Without Borders. As synthetic biology, genome editing, gene drives, CRISPR, and the biotechnologies of tomorrow continue to emerge, international treaties are struggling to keep pace. While recognizing that biotechnologies are rapidly developing, with potential benefits and potential adverse impacts; how will treaties develop governance systems to both enable benefits while preventing or minimizing adverse effects? How do international treaties that address access and benefits sharing agreements based on “physical genetic material” incorporate (or not) digital sequence information? If engineered gene drives do not recognize a country’s or indigenous community’s sovereign lands; how does the international community address a situation where one country decides to move forward while another, or indigenous community, says no? And how does the International Union for Conservation of Nature, the global authority on the status of the natural world and the measures needed to safeguard it, incorporate (or not), the tools of biotechnology? These are just some of the complicated questions international treaties have been debating over the last 10 years. Join us for a discussion as I examine these and other issues through my personal experiences inside these debates....

Continue reading "Todd Kuiken Seminar: Governance of Emerging Biotechnologies in a World Without Borders"